Sullivan Edward Aloysius Jr.'s Form 4 filing
Comera Life Sciences Holdings, Inc. (CMRA) · filed Jan 6, 2023
- Accession no.
- 0001062993-23-000608
- Filed
- Jan 6, 2023, 4:14 PM ET
- Trade date
- Jan 4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001062993-23-003495 (Feb 14, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sullivan Edward Aloysius Jr.CIK 0001929093 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | AGrant or awardAcquired | +10,979 | $1.23 | +$13,504.17 | 19,665 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | AGrant or awardAcquired | +21,958 | $0.25 | +$2,744.75 | 10,979 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.